Microcephaly-associated protein WDR62 supports purine metabolism by interacting with co-chaperone BAG2

Matthew J Morris1, Yvonne Y Yeap1,2, Jonathon R Edwards1

  • 1School of Biomedical Sciences, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Brisbane, QLD, 4072, Australia.

The EMBO Journal
|March 5, 2026
PubMed

Insights

WDR62 protein regulates purine metabolism and interacts with BAG2. Mutations in WDR62 impair purine synthesis, impacting brain development and causing microcephaly.

Area of Science:

  • Cell Biology
  • Neuroscience
  • Biochemistry

Background:

  • WDR62 is known to regulate spindle dynamics, cell division, and brain development.
  • Inherited mutations in WDR62 cause autosomal recessive primary microcephaly.

Purpose of the Study:

  • To identify novel functions of WDR62.
  • To investigate the role of WDR62 in purine metabolism and its connection to primary microcephaly.

Main Methods:

  • Investigated WDR62 interaction with BAG2, a co-chaperone of HSP70/90.
  • Analyzed WDR62 and BAG2 relocalization under stress conditions.
  • Assessed purine synthesis and salvage pathways in WDR62-deficient cells.
  • Studied the effects of WDR62 and HPRT depletion in mouse neocortex development.

Main Results:

  • WDR62 directly interacts with BAG2, and both relocalize to cytoplasmic granules under stress.
  • WDR62 deficiency impairs purine synthesis and leads to cytotoxicity upon purine deprivation.
  • Microcephaly-associated WDR62 mutations disrupt BAG2 interaction and HPRT levels.
  • In utero depletion of WDR62 or HPRT in mice causes premature neural precursor cell delamination and migration.

Conclusions:

  • WDR62 plays a regulatory role in purine metabolism.
  • Dysregulation of WDR62-mediated purine metabolism contributes to primary microcephaly.
  • WDR62 and HPRT exhibit distinct effects on neural precursor cell self-renewal, proliferation, and differentiation.

Related Concept Videos

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
49
Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
1.4K
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
5.4K
Phase II Reactions: Glucuronidation01:24

Phase II Reactions: Glucuronidation

Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
1.9K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
56
Phase II Reactions: Miscellaneous Conjugation Reactions01:19

Phase II Reactions: Miscellaneous Conjugation Reactions

Phase II biotransformations are detoxification mechanisms that conjugate xenobiotics with endogenous substances, neutralizing their toxicity.
A key example involves the conjugation of cyanide ions, which impair cellular respiration and alter hemoglobin into non-oxygen-carrying cyanmethemoglobin. To neutralize this threat, a sulfur atom from thiosulphate is transferred to the cyanide ion, catalyzed by the enzyme rhodanese, resulting in an inactive compound called thiocyanate. The production of...
425